Global Monoclonal Antibodies Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Monoclonal Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Monoclonal Antibodies market size is estimated to be worth US$ 108850 million in 2021 and is forecast to a readjusted size of USD 145840 million by 2028 with a CAGR of 4.3% during review period. Anti-Cancer accounting for % of the Monoclonal Antibodies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Erythropoietin (EPO) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Monoclonal Antibodies include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, and 3SBio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Monoclonal Antibodies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Monoclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Monoclonal Antibodies, with price, sales, revenue and global market share of Monoclonal Antibodies from 2019 to 2022.
Chapter 3, the Monoclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Monoclonal Antibodies.
Chapter 13, 14, and 15, to describe Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Monoclonal Antibodies market size is estimated to be worth US$ 108850 million in 2021 and is forecast to a readjusted size of USD 145840 million by 2028 with a CAGR of 4.3% during review period. Anti-Cancer accounting for % of the Monoclonal Antibodies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Erythropoietin (EPO) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Monoclonal Antibodies include Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, and 3SBio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Monoclonal Antibodies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Erythropoietin (EPO)
- Human Growth Hormone (HGH)
- Granulocyte- Colony Stimulating Factor (G-CSF)
- Monoclonal Antibody (mAb)
- Insulin
- Interferon (IFN)
- Others
- Anti-Cancer
- Anti-Inflammatory/Autoimmune
- Biocon
- Celltrion
- Dr. Reddy's Laboratories
- Hospira
- 3SBio
- Accord Healthcare
- AET Biotech
- Allergan
- Amega Biotech
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Monoclonal Antibodies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Monoclonal Antibodies, with price, sales, revenue and global market share of Monoclonal Antibodies from 2019 to 2022.
Chapter 3, the Monoclonal Antibodies competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Monoclonal Antibodies breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Monoclonal Antibodies.
Chapter 13, 14, and 15, to describe Monoclonal Antibodies sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Monoclonal Antibodies Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Monoclonal Antibodies Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Global Monoclonal Antibodies Market Size & Forecast
1.4.1 Global Monoclonal Antibodies Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Monoclonal Antibodies Sales in Volume (2017-2028)
1.4.3 Global Monoclonal Antibodies Price (2017-2028)
1.5 Global Monoclonal Antibodies Production Capacity Analysis
1.5.1 Global Monoclonal Antibodies Total Production Capacity (2017-2028)
1.5.2 Global Monoclonal Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibodies Market Drivers
1.6.2 Monoclonal Antibodies Market Restraints
1.6.3 Monoclonal Antibodies Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business
2.1.3 Biocon Monoclonal Antibodies Product and Services
2.1.4 Biocon Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celltrion
2.2.1 Celltrion Details
2.2.2 Celltrion Major Business
2.2.3 Celltrion Monoclonal Antibodies Product and Services
2.2.4 Celltrion Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dr. Reddy's Laboratories
2.3.1 Dr. Reddy's Laboratories Details
2.3.2 Dr. Reddy's Laboratories Major Business
2.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
2.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hospira
2.4.1 Hospira Details
2.4.2 Hospira Major Business
2.4.3 Hospira Monoclonal Antibodies Product and Services
2.4.4 Hospira Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 3SBio
2.5.1 3SBio Details
2.5.2 3SBio Major Business
2.5.3 3SBio Monoclonal Antibodies Product and Services
2.5.4 3SBio Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Accord Healthcare
2.6.1 Accord Healthcare Details
2.6.2 Accord Healthcare Major Business
2.6.3 Accord Healthcare Monoclonal Antibodies Product and Services
2.6.4 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AET Biotech
2.7.1 AET Biotech Details
2.7.2 AET Biotech Major Business
2.7.3 AET Biotech Monoclonal Antibodies Product and Services
2.7.4 AET Biotech Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business
2.8.3 Allergan Monoclonal Antibodies Product and Services
2.8.4 Allergan Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amega Biotech
2.9.1 Amega Biotech Details
2.9.2 Amega Biotech Major Business
2.9.3 Amega Biotech Monoclonal Antibodies Product and Services
2.9.4 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 MONOCLONAL ANTIBODIES BREAKDOWN DATA BY MANUFACTURER
3.1 Global Monoclonal Antibodies Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Monoclonal Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2021
3.4.2 Top 6 Monoclonal Antibodies Manufacturer Market Share in 2021
3.5 Global Monoclonal Antibodies Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Monoclonal Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Monoclonal Antibodies Market Size by Region
4.1.1 Global Monoclonal Antibodies Sales in Volume by Region (2017-2028)
4.1.2 Global Monoclonal Antibodies Revenue by Region (2017-2028)
4.2 North America Monoclonal Antibodies Revenue (2017-2028)
4.3 Europe Monoclonal Antibodies Revenue (2017-2028)
4.4 Asia-Pacific Monoclonal Antibodies Revenue (2017-2028)
4.5 South America Monoclonal Antibodies Revenue (2017-2028)
4.6 Middle East and Africa Monoclonal Antibodies Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Monoclonal Antibodies Sales in Volume by Type (2017-2028)
5.2 Global Monoclonal Antibodies Revenue by Type (2017-2028)
5.3 Global Monoclonal Antibodies Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monoclonal Antibodies Sales in Volume by Application (2017-2028)
6.2 Global Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 Global Monoclonal Antibodies Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
7.2 North America Monoclonal Antibodies Sales by Application (2017-2028)
7.3 North America Monoclonal Antibodies Market Size by Country
7.3.1 North America Monoclonal Antibodies Sales in Volume by Country (2017-2028)
7.3.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
8.2 Europe Monoclonal Antibodies Sales by Application (2017-2028)
8.3 Europe Monoclonal Antibodies Market Size by Country
8.3.1 Europe Monoclonal Antibodies Sales in Volume by Country (2017-2028)
8.3.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Monoclonal Antibodies Sales by Type (2017-2028)
9.2 Asia-Pacific Monoclonal Antibodies Sales by Application (2017-2028)
9.3 Asia-Pacific Monoclonal Antibodies Market Size by Region
9.3.1 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Monoclonal Antibodies Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Monoclonal Antibodies Sales by Type (2017-2028)
10.2 South America Monoclonal Antibodies Sales by Application (2017-2028)
10.3 South America Monoclonal Antibodies Market Size by Country
10.3.1 South America Monoclonal Antibodies Sales in Volume by Country (2017-2028)
10.3.2 South America Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Monoclonal Antibodies Sales by Type (2017-2028)
11.2 Middle East & Africa Monoclonal Antibodies Sales by Application (2017-2028)
11.3 Middle East & Africa Monoclonal Antibodies Market Size by Country
11.3.1 Middle East & Africa Monoclonal Antibodies Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Monoclonal Antibodies Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Monoclonal Antibodies and Key Manufacturers
12.2 Manufacturing Costs Percentage of Monoclonal Antibodies
12.3 Monoclonal Antibodies Production Process
12.4 Monoclonal Antibodies Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Monoclonal Antibodies Typical Distributors
13.3 Monoclonal Antibodies Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Monoclonal Antibodies Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Monoclonal Antibodies Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Global Monoclonal Antibodies Market Size & Forecast
1.4.1 Global Monoclonal Antibodies Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Monoclonal Antibodies Sales in Volume (2017-2028)
1.4.3 Global Monoclonal Antibodies Price (2017-2028)
1.5 Global Monoclonal Antibodies Production Capacity Analysis
1.5.1 Global Monoclonal Antibodies Total Production Capacity (2017-2028)
1.5.2 Global Monoclonal Antibodies Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibodies Market Drivers
1.6.2 Monoclonal Antibodies Market Restraints
1.6.3 Monoclonal Antibodies Trends Analysis
2 MANUFACTURERS PROFILES
2.1 Biocon
2.1.1 Biocon Details
2.1.2 Biocon Major Business
2.1.3 Biocon Monoclonal Antibodies Product and Services
2.1.4 Biocon Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celltrion
2.2.1 Celltrion Details
2.2.2 Celltrion Major Business
2.2.3 Celltrion Monoclonal Antibodies Product and Services
2.2.4 Celltrion Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Dr. Reddy's Laboratories
2.3.1 Dr. Reddy's Laboratories Details
2.3.2 Dr. Reddy's Laboratories Major Business
2.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
2.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hospira
2.4.1 Hospira Details
2.4.2 Hospira Major Business
2.4.3 Hospira Monoclonal Antibodies Product and Services
2.4.4 Hospira Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 3SBio
2.5.1 3SBio Details
2.5.2 3SBio Major Business
2.5.3 3SBio Monoclonal Antibodies Product and Services
2.5.4 3SBio Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Accord Healthcare
2.6.1 Accord Healthcare Details
2.6.2 Accord Healthcare Major Business
2.6.3 Accord Healthcare Monoclonal Antibodies Product and Services
2.6.4 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 AET Biotech
2.7.1 AET Biotech Details
2.7.2 AET Biotech Major Business
2.7.3 AET Biotech Monoclonal Antibodies Product and Services
2.7.4 AET Biotech Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business
2.8.3 Allergan Monoclonal Antibodies Product and Services
2.8.4 Allergan Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amega Biotech
2.9.1 Amega Biotech Details
2.9.2 Amega Biotech Major Business
2.9.3 Amega Biotech Monoclonal Antibodies Product and Services
2.9.4 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 MONOCLONAL ANTIBODIES BREAKDOWN DATA BY MANUFACTURER
3.1 Global Monoclonal Antibodies Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Monoclonal Antibodies
3.4 Market Concentration Rate
3.4.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2021
3.4.2 Top 6 Monoclonal Antibodies Manufacturer Market Share in 2021
3.5 Global Monoclonal Antibodies Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Monoclonal Antibodies Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 MARKET ANALYSIS BY REGION
4.1 Global Monoclonal Antibodies Market Size by Region
4.1.1 Global Monoclonal Antibodies Sales in Volume by Region (2017-2028)
4.1.2 Global Monoclonal Antibodies Revenue by Region (2017-2028)
4.2 North America Monoclonal Antibodies Revenue (2017-2028)
4.3 Europe Monoclonal Antibodies Revenue (2017-2028)
4.4 Asia-Pacific Monoclonal Antibodies Revenue (2017-2028)
4.5 South America Monoclonal Antibodies Revenue (2017-2028)
4.6 Middle East and Africa Monoclonal Antibodies Revenue (2017-2028)
5 MARKET SEGMENT BY TYPE
5.1 Global Monoclonal Antibodies Sales in Volume by Type (2017-2028)
5.2 Global Monoclonal Antibodies Revenue by Type (2017-2028)
5.3 Global Monoclonal Antibodies Price by Type (2017-2028)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monoclonal Antibodies Sales in Volume by Application (2017-2028)
6.2 Global Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 Global Monoclonal Antibodies Price by Application (2017-2028)
7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
7.2 North America Monoclonal Antibodies Sales by Application (2017-2028)
7.3 North America Monoclonal Antibodies Market Size by Country
7.3.1 North America Monoclonal Antibodies Sales in Volume by Country (2017-2028)
7.3.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
8.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
8.2 Europe Monoclonal Antibodies Sales by Application (2017-2028)
8.3 Europe Monoclonal Antibodies Market Size by Country
8.3.1 Europe Monoclonal Antibodies Sales in Volume by Country (2017-2028)
8.3.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
9.1 Asia-Pacific Monoclonal Antibodies Sales by Type (2017-2028)
9.2 Asia-Pacific Monoclonal Antibodies Sales by Application (2017-2028)
9.3 Asia-Pacific Monoclonal Antibodies Market Size by Region
9.3.1 Asia-Pacific Monoclonal Antibodies Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Monoclonal Antibodies Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION
10.1 South America Monoclonal Antibodies Sales by Type (2017-2028)
10.2 South America Monoclonal Antibodies Sales by Application (2017-2028)
10.3 South America Monoclonal Antibodies Market Size by Country
10.3.1 South America Monoclonal Antibodies Sales in Volume by Country (2017-2028)
10.3.2 South America Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
11.1 Middle East & Africa Monoclonal Antibodies Sales by Type (2017-2028)
11.2 Middle East & Africa Monoclonal Antibodies Sales by Application (2017-2028)
11.3 Middle East & Africa Monoclonal Antibodies Market Size by Country
11.3.1 Middle East & Africa Monoclonal Antibodies Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Monoclonal Antibodies Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 RAW MATERIAL AND INDUSTRY CHAIN
12.1 Raw Material of Monoclonal Antibodies and Key Manufacturers
12.2 Manufacturing Costs Percentage of Monoclonal Antibodies
12.3 Monoclonal Antibodies Production Process
12.4 Monoclonal Antibodies Industrial Chain
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Monoclonal Antibodies Typical Distributors
13.3 Monoclonal Antibodies Typical Customers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Monoclonal Antibodies Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Monoclonal Antibodies Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Biocon Basic Information, Manufacturing Base and Competitors
Table 4. Biocon Major Business
Table 5. Biocon Monoclonal Antibodies Product and Services
Table 6. Biocon Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Celltrion Basic Information, Manufacturing Base and Competitors
Table 8. Celltrion Major Business
Table 9. Celltrion Monoclonal Antibodies Product and Services
Table 10. Celltrion Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddy's Laboratories Major Business
Table 13. Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
Table 14. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hospira Basic Information, Manufacturing Base and Competitors
Table 16. Hospira Major Business
Table 17. Hospira Monoclonal Antibodies Product and Services
Table 18. Hospira Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. 3SBio Basic Information, Manufacturing Base and Competitors
Table 20. 3SBio Major Business
Table 21. 3SBio Monoclonal Antibodies Product and Services
Table 22. 3SBio Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Accord Healthcare Major Business
Table 25. Accord Healthcare Monoclonal Antibodies Product and Services
Table 26. Accord Healthcare Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AET Biotech Basic Information, Manufacturing Base and Competitors
Table 28. AET Biotech Major Business
Table 29. AET Biotech Monoclonal Antibodies Product and Services
Table 30. AET Biotech Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Allergan Basic Information, Manufacturing Base and Competitors
Table 32. Allergan Major Business
Table 33. Allergan Monoclonal Antibodies Product and Services
Table 34. Allergan Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amega Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Amega Biotech Major Business
Table 37. Amega Biotech Monoclonal Antibodies Product and Services
Table 38. Amega Biotech Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Monoclonal Antibodies Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Monoclonal Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Monoclonal Antibodies Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and Monoclonal Antibodies Production Site of Key Manufacturer
Table 44. Monoclonal Antibodies New Entrant and Capacity Expansion Plans
Table 45. Monoclonal Antibodies Mergers & Acquisitions in the Past Five Years
Table 46. Global Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 47. Global Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 48. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 51. Global Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 52. Global Monoclonal Antibodies Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Monoclonal Antibodies Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Monoclonal Antibodies Price by Type (2017-2022) & (USD/Kg)
Table 55. Global Monoclonal Antibodies Price by Type (2023-2028) & (USD/Kg)
Table 56. Global Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 57. Global Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 58. Global Monoclonal Antibodies Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Monoclonal Antibodies Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Monoclonal Antibodies Price by Application (2017-2022) & (USD/Kg)
Table 61. Global Monoclonal Antibodies Price by Application (2023-2028) & (USD/Kg)
Table 62. North America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 63. North America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 64. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 67. North America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 68. North America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 69. North America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 70. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 71. Europe Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 72. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 75. Europe Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 76. Europe Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 77. Europe Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 83. Asia-Pacific Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 84. Asia-Pacific Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 86. South America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 87. South America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 88. South America Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 91. South America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 92. South America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 93. South America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 99. Middle East & Africa Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 100. Middle East & Africa Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 102. Monoclonal Antibodies Raw Material
Table 103. Key Manufacturers of Monoclonal Antibodies Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Monoclonal Antibodies Typical Distributors
Table 107. Monoclonal Antibodies Typical Customers
Table 1. Global Monoclonal Antibodies Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Monoclonal Antibodies Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Biocon Basic Information, Manufacturing Base and Competitors
Table 4. Biocon Major Business
Table 5. Biocon Monoclonal Antibodies Product and Services
Table 6. Biocon Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Celltrion Basic Information, Manufacturing Base and Competitors
Table 8. Celltrion Major Business
Table 9. Celltrion Monoclonal Antibodies Product and Services
Table 10. Celltrion Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Reddy's Laboratories Major Business
Table 13. Dr. Reddy's Laboratories Monoclonal Antibodies Product and Services
Table 14. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hospira Basic Information, Manufacturing Base and Competitors
Table 16. Hospira Major Business
Table 17. Hospira Monoclonal Antibodies Product and Services
Table 18. Hospira Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. 3SBio Basic Information, Manufacturing Base and Competitors
Table 20. 3SBio Major Business
Table 21. 3SBio Monoclonal Antibodies Product and Services
Table 22. 3SBio Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Accord Healthcare Major Business
Table 25. Accord Healthcare Monoclonal Antibodies Product and Services
Table 26. Accord Healthcare Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. AET Biotech Basic Information, Manufacturing Base and Competitors
Table 28. AET Biotech Major Business
Table 29. AET Biotech Monoclonal Antibodies Product and Services
Table 30. AET Biotech Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Allergan Basic Information, Manufacturing Base and Competitors
Table 32. Allergan Major Business
Table 33. Allergan Monoclonal Antibodies Product and Services
Table 34. Allergan Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amega Biotech Basic Information, Manufacturing Base and Competitors
Table 36. Amega Biotech Major Business
Table 37. Amega Biotech Monoclonal Antibodies Product and Services
Table 38. Amega Biotech Monoclonal Antibodies Sales (Kg), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Monoclonal Antibodies Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 40. Global Monoclonal Antibodies Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Monoclonal Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Monoclonal Antibodies Production Capacity by Company, (Kg): 2020 VS 2021
Table 43. Head Office and Monoclonal Antibodies Production Site of Key Manufacturer
Table 44. Monoclonal Antibodies New Entrant and Capacity Expansion Plans
Table 45. Monoclonal Antibodies Mergers & Acquisitions in the Past Five Years
Table 46. Global Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 47. Global Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 48. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 51. Global Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 52. Global Monoclonal Antibodies Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Monoclonal Antibodies Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Monoclonal Antibodies Price by Type (2017-2022) & (USD/Kg)
Table 55. Global Monoclonal Antibodies Price by Type (2023-2028) & (USD/Kg)
Table 56. Global Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 57. Global Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 58. Global Monoclonal Antibodies Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Monoclonal Antibodies Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Monoclonal Antibodies Price by Application (2017-2022) & (USD/Kg)
Table 61. Global Monoclonal Antibodies Price by Application (2023-2028) & (USD/Kg)
Table 62. North America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 63. North America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 64. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 67. North America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 68. North America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 69. North America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 70. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 71. Europe Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 72. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 75. Europe Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 76. Europe Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 77. Europe Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 78. Asia-Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 79. Asia-Pacific Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 80. Asia-Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 83. Asia-Pacific Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 84. Asia-Pacific Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 85. Asia-Pacific Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 86. South America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 87. South America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 88. South America Monoclonal Antibodies Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Monoclonal Antibodies Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 91. South America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 92. South America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 93. South America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 94. Middle East & Africa Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 95. Middle East & Africa Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 96. Middle East & Africa Monoclonal Antibodies Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Monoclonal Antibodies Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 99. Middle East & Africa Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 100. Middle East & Africa Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 101. Middle East & Africa Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 102. Monoclonal Antibodies Raw Material
Table 103. Key Manufacturers of Monoclonal Antibodies Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Monoclonal Antibodies Typical Distributors
Table 107. Monoclonal Antibodies Typical Customers
LIST OF FIGURES
Figure 1. Monoclonal Antibodies Picture
Figure 2. Global Monoclonal Antibodies Revenue Market Share by Type in 2021
Figure 3. Erythropoietin (EPO)
Figure 4. Human Growth Hormone (HGH)
Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF)
Figure 6. Monoclonal Antibody (mAb)
Figure 7. Insulin
Figure 8. Interferon (IFN)
Figure 9. Others
Figure 10. Global Monoclonal Antibodies Revenue Market Share by Application in 2021
Figure 11. Anti-Cancer
Figure 12. Anti-Inflammatory/Autoimmune
Figure 13. Global Monoclonal Antibodies Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 14. Global Monoclonal Antibodies Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Monoclonal Antibodies Sales (2017-2028) & (Kg)
Figure 16. Global Monoclonal Antibodies Price (2017-2028) & (USD/Kg)
Figure 17. Global Monoclonal Antibodies Production Capacity (2017-2028) & (Kg)
Figure 18. Global Monoclonal Antibodies Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Monoclonal Antibodies Market Drivers
Figure 20. Monoclonal Antibodies Market Restraints
Figure 21. Monoclonal Antibodies Market Trends
Figure 22. Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2021
Figure 23. Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Figure 24. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 28. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 29. North America Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 30. Europe Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 32. South America Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 34. Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 35. Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 36. Global Monoclonal Antibodies Price by Type (2017-2028) & (USD/Kg)
Figure 37. Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 38. Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 39. Global Monoclonal Antibodies Price by Application (2017-2028) & (USD/Kg)
Figure 40. North America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 41. North America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 42. North America Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 43. North America Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 44. United States Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 48. Europe Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 49. Europe Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 50. Europe Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 51. Germany Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 60. China Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 67. South America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 68. South America Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 69. South America Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Monoclonal Antibodies in 2021
Figure 81. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 82. Monoclonal Antibodies Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Monoclonal Antibodies Picture
Figure 2. Global Monoclonal Antibodies Revenue Market Share by Type in 2021
Figure 3. Erythropoietin (EPO)
Figure 4. Human Growth Hormone (HGH)
Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF)
Figure 6. Monoclonal Antibody (mAb)
Figure 7. Insulin
Figure 8. Interferon (IFN)
Figure 9. Others
Figure 10. Global Monoclonal Antibodies Revenue Market Share by Application in 2021
Figure 11. Anti-Cancer
Figure 12. Anti-Inflammatory/Autoimmune
Figure 13. Global Monoclonal Antibodies Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 14. Global Monoclonal Antibodies Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Monoclonal Antibodies Sales (2017-2028) & (Kg)
Figure 16. Global Monoclonal Antibodies Price (2017-2028) & (USD/Kg)
Figure 17. Global Monoclonal Antibodies Production Capacity (2017-2028) & (Kg)
Figure 18. Global Monoclonal Antibodies Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Monoclonal Antibodies Market Drivers
Figure 20. Monoclonal Antibodies Market Restraints
Figure 21. Monoclonal Antibodies Market Trends
Figure 22. Global Monoclonal Antibodies Sales Market Share by Manufacturer in 2021
Figure 23. Global Monoclonal Antibodies Revenue Market Share by Manufacturer in 2021
Figure 24. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Monoclonal Antibodies Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 28. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 29. North America Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 30. Europe Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 32. South America Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Monoclonal Antibodies Revenue (2017-2028) & (USD Million)
Figure 34. Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 35. Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 36. Global Monoclonal Antibodies Price by Type (2017-2028) & (USD/Kg)
Figure 37. Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 38. Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 39. Global Monoclonal Antibodies Price by Application (2017-2028) & (USD/Kg)
Figure 40. North America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 41. North America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 42. North America Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 43. North America Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 44. United States Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 48. Europe Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 49. Europe Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 50. Europe Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 51. Germany Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 60. China Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 67. South America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 68. South America Monoclonal Antibodies Sales Market Share by Country (2017-2028)
Figure 69. South America Monoclonal Antibodies Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Monoclonal Antibodies Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Monoclonal Antibodies Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Monoclonal Antibodies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Monoclonal Antibodies in 2021
Figure 81. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 82. Monoclonal Antibodies Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
